Compliance with treatment: Related-issues and insights for pharmacist intervention

Brazilian Journal of Pharmaceutical Sciences

Volumn 47, Issue 1, 2011, Pages 1-12

  da Silva, Nilcéia Lopes ^a,b   Ribeiro, Eliane ^a   Navarro, João Luis ^b   Zanini, Antonio Carlos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Cardiovascular and Metabolism Unit   (Brazil)

Author keywords

Chronic diseases therapy; Medicines use; Pharmacists interventions; Pharmacotherapy compliance with treatment

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADVERSE DRUG REACTION; ANALYTIC METHOD; ARTICLE; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CLINICAL PHARMACY; COGNITIVE DEFECT; DOCTOR PATIENT RELATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG THERAPY; FACTORIAL ANALYSIS; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEDICAL CARE; MEDICAL INFORMATION; MEMORY DISORDER; NOMENCLATURE; PARAMEDICAL EDUCATION; PATIENT ATTITUDE; PATIENT CARE; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT INFORMATION; PATIENT MONITORING; PHARMACEUTICAL CARE; PHARMACIST; POLYPHARMACY; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; PROFESSIONAL PRACTICE; WORLD HEALTH ORGANIZATION;

EID: 79957540259     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. AMERICAN HEART ASSOCIATION. Third report of the National Cholesterol Education Program (NCEP) expert panel on the detection, evaluation, and treatment on high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation, v.106, n.25, p.3143-421, 2002.
2. BAILEY, J.E.; WAN, J.Y.; TANG, J.; GHANI, M.A.; CUSHMAN, W.C. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J. Gen. Intern. Med., v.25, n.6, p.495-503, 2010.
3. BISSEL, P.; MAY, C.R.; NOYCE, P.R. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc. Sci. Med., v.58, n.4, p.851-862, 2004.
4. BRAMLEY, T.J.; GERBINO, P.P.; NIGHTENGALE, B.S.; FRECH-TAMAS, F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J. Manag. Care Pharm., v.12, n.3, p.239-245, 2006.
5. BRASIL. MINISTÉRIO DA SAÚDE. Indicadores e dados básicos-Brasil-2008. IDB-2008. Available at: . Accessed on: 27 jun. 2010.
6. BREELVELDT-POSTMA, N.S.; PENNING-VAN BEEST, F.J.A.; SIISKONEN, S.J.; FALVEY, H.; VINCZE, G.; KLUNGEL, O.H.; HERINGS, R.M.C. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr. Med. Res. Opin., v.24, n.1, p.121-127, 2008.
7. BURNIER, M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am. J. Hypertens., v.19, n.11, p.1190-196, 2006.
8. CASTRO, M.S.; FUCHS, F.D.; SANTOS, M. C; MAXIMILIANO, P.; GUS, M.; MOREIRA, L.B.; FERREIRA, M.B.C. Pharmaceutical Care Program for Patients With Uncontrolled Hypertension. Report of a Double-Blind Clinical Trial with Ambulatory Blood Pressure Monitoring. Am. J. Hypertens., v.19, n.5, p.528-533, 2006.
9. CHAN, Y.M.; MOLASSIOTIS, A. The relationship between knowledge and compliance among Chinese with non-insulin dependent diabetes mellitus in Hong Kong. J. Adv. Nurs., v.30, n.2, p.431-438, 1999.
10. CLAXTON, A.J.; CRAMER, J.; PIERCE, C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther., v.23, n.8, p.1296-1310, 2001.
11. CRAMER, J. A systematic review of adherence with medications for diabetes. Diabetes Care, v.27, n.9, p.1218-1224, 2004.
12. CRAMER, J.A.; ROY, A.; BURRELL, A.; FAIRCHILD, C.J.; FULDEORE, M.J.; OLLENDORF, D.A.; WONG, P.K. Medication compliance and persistence: terminology and definitions. Value Health, v.11, n.1, p.44-47, 2008a.
13. CRAMER, J.A.; BENEDICT, A.; MUSZBECK, N.; KESKINASLAN, A.; KHAN, Z.M. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int. J. Clin. Pract., v.62, n.1, p.76-87, 2008b.
14. DELAMATER, A.M. Improving patient adherence. Clin. Diabet., v.24, n.2, p.71-77, 2006.
15. DELGADO, A.B.; LIMA, M.L. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicol. Saúde Doenças, v.2, n.2, p.81-100, 2001.
16. DURU, O.K.; SCHMITTDIEL, J.A., DYER, W.T., PARKER, M.M.; URATSU, C.S.; CHAN, J.; KARTER, A.J. Mail-order pharmacy use and adherence to diabetes-related medications. Am. J. Manag. Care, v.16, n.1, p.33-40, 2010.
17. ELLIOTT, R.A.; BARBER, N.; CLIFFORD, S.; HORNE, R.; HARTLEY, E. The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines. Pharm. World Sci., v.30, n.1, p.17-23, 2008.
18. FERREIRA, L.D.; QUEIROZ, M.U.; BORGES, A.P.S.; PEREIRA, L.R.L. Avaliação da importância da atenção farmacêutica no controle glicêmico dos usuários portadores de diabetes mellitus tipo 2 (dm2) atendidos por uma Unidade Básica de Saúde em Ribeirão Preto-SP. 2006 Available at: . Accessed on: 2 nov. 2009.
19. GATTI, M.E.; JACOBSON, K.L.; GAZMARARIAN, J.A.; SCHMOTZER, B., KRIPALANI, S. Relationships between beliefs about medications and adherence. Am. J. Health. Syst. Pharm., v.66, n.7, p.657-664, 2009.
20. GLYNN, L.G.; MURPHY, A.W.; SMITH, S.M.; SCHROEDER, K.; FAHEY, T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database of Systematic Review, v.3, 2010. Available at: . Accessed on: 02 sep. 2010.
21. GOLIN, C.E.; DIMATTEO, M.R.; GELBER, G.L. The role of patient participation in the doctor visit: implications for adherence to diabetes care. Diabetes Care, v.9, n.10, p.1153-1164, 1996.
22. GOTTLIEB, H. Medication nonadherence: finding solutions to a costly medical problem. Drug Benefit Trends, v.12, n.6, p.57-62, 2000.
23. GUSMÃO, J.L.; MION Jr., D. Adesão ao tratamento: conceitos. Rev. Bras. Hipertens., v.13, n.1, p.23-25, 2006.
24. GUSMÃO, J.L.; GINANI, G.F.; SILVA, G.V.; ORTEGA, K.C. MION, Jr, D. Adesão ao tratamento em hipertensão arterial sistólica isolada. Rev. Bras. Hipertens., v.16, n.1, p.38-43, 2009.
25. HALPERN, M.T.; KHAN, Z.M.; SCHMIER, J.K.; BURNIER, M.; CARO, J.J.; CRAMER, J.; DALEY, W.L.; GURWITZ, J.; HOLLENBERG, N.K. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension, v.47, n.6, p.1039-1048, 2006.
26. HOBDEN, A. Concordance: a widely used term, but what does it mean? Br. J. Community Nurs., v.11, n.6, p.257-260, 2006.
27. ISKEDJIAN, M.; EINARSON, T.R.; MACKEIGAN, L.D.; SHEAR, N.; ADDIS, A.; MITTMANN, N.; ILERSICH, A.L. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin. Ther., v.24, n.2, p.302-316, 2002.
28. KABOLI, P.J.; HOTH, A.B.; McCLIMON, B.J.; SCHNIPPER, J.L. Clinical pharmacists and inpatient medical care: a systematic review. Arch. Intern. Med., v.166, p.955-964, 2006.
29. KENREIGH, C.A.; WAGNER, L.T. Medication adherence: a literature review. Medscape Pharmacists, v.6, n.2, 2005. Available at: . Accessed on: 7 sep. 2007.
30. KRIPALANI, S.; RISSER, J.; GATTI, M.E.; JACOBSON, T.A. Development and evaluation of the adherence to refills and medications scale (ARMS) among low-literacy patients with chronic disease. Value Health, v.12, n.1, p.118-123, 2009.
31. KRUEGER, K.P.; BERGER, B.A.; FELKEY, B. Medication adherence and persistence: a comprehensive review. Adv. Ther., v.22, n.4, p.313-356, 2005.
32. LEE, J.K.; GRACE, K.A.; TAYLOR, A.J. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. J. Am. Med. Assoc., v.296, n.21, p.2563-2571, 2006.
33. LEITE, S.N.; VASCONCELOS, M.P.C. Adesão à terapêutica medicamentosa: elementos para a discussão de conceitos e pressupostos adotados na literatura. Ciênc. Saúde Coletiva, v.8, n.33, p.775-782, 2003.
34. LESSA, I. Impacto social da não-adesão ao tratamento da hipertensão arterial. Rev. Bras. Hipertens., v.13, n.1, p.39-46, 2006.
35. LUTFEY, K.E.; WISHNER, W.J. Beyond "compliance" is "adherence": improving the prospect of diabete care. Diabetes Care, v.22, n.4, p.635-639, 1999.
36. MARTINS, C.B.; PAROLINA, R.D.; CARAVANTE Jr, F.P.G.; FARHAT, F.C.L. G; CARMO, T.A. Melhoria da adesão ao tratamento medicamentoso de portadores de diabetes mellitus e hipertensão arterial por meio da atenção farmacêutica. In: AMOSTRA ACADÊMICA UNIMEP, 5., Piracicaba, 2007. Posters. Available at: . Accessed on: 2 nov. 2009.
37. MORI, A.L.P.M.; YOCHIY, A.; STORPIRTIS, S. Educação sanitária. In: STORPIRTIS, S.; MORI, A.L.P.M.; YOCHIY, A.; RIBEIRO, E.; PORTA, V. Farmácia clínica e atenção farmacêutica. Rio de Janeiro: Guanabara Koogan, 2008. cap.31, p.298-306.
38. MORISKY, D.E.; GREEN, L.W.; LEVINE, D.M. Concurrent and predictive validity of self-reported measure of medication adherence. Med. Care, v.24, p.67-74, 1986.
39. MURRAY, M.D.; MORROW, D.G.; WEINER, M.; CLARK, D.O.; TU, W.; DEER, M.M.; BRATER, C.; WEINSBERG, M. A conceptual framework to study medication adherence in older adults. Am. J. Geriatr. Pharmacother., v.2, n.1, p.36-43, 2004.
40. MUSZBEK, N.; BRIXNER, A.; BENEDICT, A.; KESKINASLAN, A.; KHAN, Z.M. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. Int. J. Clin. Pract., v.62, n.2., p.338-351, 2008.
41. NEUTEL, J.M.; SMITH, D.H.G. Improving patient compliance: a major goal in the management of hypertension. J. Clin. Hypertens., v.5, n.2, p.127-132, 2003.
42. OCKENE, I.S.; HAYMAN, L.L.; PASTERNAK, R.C.; SCHRON, E.; DUNBAR-JACOB, J. Adherence issues and behavior changes: achieving a long-term solution. J. Am. Coll. Cardiol., v.40, n.4, p.630-640, 2002.
43. OIGMAN, W. Métodos de avaliação da adesão ao tratamento anti-hipertensivo. Rev. Bras. Hipertens., v.13, n.1, p.30-34, 2006.
44. OSTERBERG, L.; BLASCHKE, T. Adherence to medication. N. Engl. J. Med., v.353, p.487-497, 2005.
45. PAN AMERICAN HEALTH ORGANIZATION. Poor adherence to long-term treatment of chronic diseases is a worldwide problem. Rev. Panam. Salud Publica, v.14, n.3, p.218-221, 2003.
46. PHATAK, H.M.; THOMAS, J. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann. Pharmacother., v.40, n.10, p.1737-1742, 2006.
47. PINDOLIA, V.K.; STEBELSKY, L.; ROMAIN, T.M.; LUOMA, L.; NOWAK, S.N.; GILLANDERS, F. Mitigation of medication mishaps via medication therapy management. Ann. Pharmacother., v.43, n.4, p.611-620, 2009.
48. RASMUSSEN, J.N.; CHONG, A.; ALTER, D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. J. Am. Med. Assoc., v.297, n.2, p.177-186, 2007.
49. ROCHA Jr., M.A. Compliance-você acha que a receita vai ser seguida? In: ZANINI, A.C.; PAULO, L.G. Compliance: sobre o encontro paciente-médico. São Roque: IPEX, 1997. cap.4, p.51-66.
50. ROMANO-LIEBER, N.S.; TEIXEIRA, J.J.V.; FARHAT, F.C.L.G.; RIBEIRO, E.; CROZATTI, M.T. L; OLIVEIRA, G.S.A. Revisão dos estudos de intervenção do farmacêutico no uso de medicamentos por pacientes idosos. Cad. Saúde Pública, v.18, n.6, p.1499-1507, 2002.
51. ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN. From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain, 1997. 55 p.
52. SIKKA, R.; XIA, F.; AUBERT, R.E. Estimating medication persistency using administrative claims data. Am. J. Manag. Care, v.11, n.7, p.449-457, 2005.
53. SMITH, L.; McGOWAN, L.; MOSS-BARCCLAY, C.; WEATHER, J.; KNASS, D.; CHRYSTYN, H. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. Br. J. Clin. Pharmacol., v.44, n.2, p.163-165, 1997.
54. SOKOL, M.C.; McGUIGAN, K.A.; VERBRUGGE, R.R.; EPSTEIN, R.S. Impact of medication adherence on hospitalization risk and healthcare cost. Med. Care, v.43, n.6, p.521-530, 2005.
55. SOUZA, V. V; BERTONCIN, A.L. Atenção farmacêutica para pacientes hipertensos-nova metodologia e a importância dessa prática no acompanhamento domiciliar. Rev. Bras. Promoç. Saúde, v.21, n.3, p.224-230, 2008.
56. STRÖMBERG, A. Patient-related factors of compliance in heart failure: some new insights into old problem. Eur. Heart J., v.27, n.4, p.379-381, 2006.
57. SVARSTAD, B.L.; KOTCHEN, J.M.; SHIREMAN, T.I.; CRAWFORD, S.Y., PALMER, P.A.; VIVIAN, E.M.; BROWN, R.L. The Team Education and Adherence Monitoring (TEAM) Trial: Pharmacy Interventions to Improve Hypertension Control in Blacks. Circ. Cardiovasc. Qual. Outcomes, v.2, n.3, p.264-271, 2009.
58. TOURETTE-TURGIS, C.; REBILLON, M.; PEREIRA-PAULO, L. De l'adhésion à l'observance thérapeutique: réunir les conditions d'une primo-observance et développer une multiplicité d'interventions dans la durée. Counseling, Santé et Développement Dossiê, n.1/2, p.1-8, 2005. Available at: . Accessed on: 7 sep. 2007.
59. V DIRETRIZES Brasileiras de Hipertensão Arterial. Arq. Bras. Cardiol., v.89, n.3, p. E24-E79, 2007.
60. WAHL, C.; GREGORIE, J.P.; TEO, K.; BEAULIEU, M.; LABELLE, S.; LEDUC, B.; COGHRANE, B.; LAPOINTE, L.; MONTAGUE, T. Concordance, compliance and adherence in healthcare: closing gaps and improving outcomes. Healthcare Quarterly, v.8, n.1, p.65-70, 2005.
61. WASH, J.; McDONALD, K.M.; SHOJANIA, K.; SUNDARAM, V., NAYAK, S.; LEWIS, R.; OWENS, D.K.; GOLDSTEIN, M.K. Quality improvement strategies for hypertension management: a systematic review. Med. Care, v.44, n.7, p.646-657, 2006.
62. WORLD HEALTH ORGANIZATION. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003. 198 p.
63. WU, J.Y.F.; LEUNG, W.Y.S.; CHANG, S.; LEE, B.; ZEE, B.; TONG, P.C. Y; CHAN, J.C.N. Effectiveness of telephone counseling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomized controlled trial. BMJ, v.333, n.7567, p.522-525, 2006.
64. ZANINI, A.C.; PAULO, L.G. Expectativas, dúvidas e fantasias da consulta médica. In: PAULO, L.G.; ZANINI, A.C. Compliance: sobre o encontro paciente-médico. São Roque: IPEX, 1997. cap.1, p.1-8.